David Drutz - Aug 15, 2023 Form 4 Insider Report for Altimmune, Inc. (ALT)

Role
Director
Signature
/s/ Richard Eisenstadt, as Attorney-in-Fact
Stock symbol
ALT
Transactions as of
Aug 15, 2023
Transactions value $
$863
Form type
4
Date filed
8/15/2023, 06:46 PM
Previous filing
Mar 27, 2023
Next filing
Sep 29, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ALT Common Stock, par value $0.0001 Purchase $863 +300 +1.02% $2.88 29.8K Aug 15, 2023 See Footnote F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents Common Stock purchased and immediately transferred to Pacific Biopharma Associates, LLC.
F2 Represents Common Stock held by Pacific Biopharma Associates, LLC, of which the reporting person is the President.